Aclaris Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -1.44%49.440.0%$328.53m
VRXValeant Pharmaceuticals International, Inc. 1.28%28.4314.1%$167.29m
HZNPHorizon Therapeutics Plc 0.56%113.585.5%$129.05m
ICLRICON plc 0.60%278.242.8%$116.66m
CTLTCatalent, Inc. 1.88%132.852.0%$102.14m
JAZZJazz Pharmaceuticals Plc 2.02%143.202.1%$95.50m
PRGOPerrigo Co. Plc 2.64%45.956.9%$75.78m
UTHRUnited Therapeutics Corp. 1.03%186.2314.0%$64.95m
ARGXargenx SE 1.91%297.500.0%$53.40m
BHCBausch Health Cos., Inc. 1.25%28.420.0%$44.02m
AXSMAxsome Therapeutics, Inc. -0.12%41.071.8%$42.02m
GRVIGrove, Inc. 2.59%6.330.0%$37.85m
PCRXPacira Biosciences, Inc. -0.90%52.609.8%$32.21m
ENDPEndo International Plc 0.36%4.188.5%$31.80m
IRWDIronwood Pharmaceuticals, Inc. -0.22%13.389.5%$24.15m

Company Profile

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.